BioArctic AB (FRA:B9A) FFO


FRA:B9A BioArctic AB FRA:B9A
84 GF Score
Price €29.72
GF Value €41.45
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is BioArctic AB FFO?

FFO (Funds from operations) only applies to REITs.

FRA:B9A
84GF Score
BioArctic AB FRA:B9A
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BioArctic AB (FRA:B9A) Overvalued in 2026?

Based on GuruFocus' analysis, BioArctic AB stock appears to be undervalued. The current stock price of €29.72 is trading 28.3% below its estimated GF Value™ of €41.45. GuruFocus considers BioArctic AB to be Modestly Undervalued.

Key valuation signals for FRA:B9A:

  • FFO:
  • GF Value™: €41.45 vs. price of €29.72 (28.3% below fair value)
  • GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the FRA:B9A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioArctic AB Business Description

Address Warfvinges vag 35, Stockholm, SWE, SE-112 51
BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. Geographically, it derives a majority of its revenue from North America.
84GF Score

Get the complete analysis for FRA:B9A

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€29.72
Price
€41.45
GF Value